Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Pembrolizumab Plus CCRT Improves Overall Survival
BARCELONA, Spain — Adding pembrolizumab to standard concurrent chemoradiotherapy (CCRT) significantly improves overall survival in patients with high-risk, locally advanced cervical cancer, according to results of a phase 3, randomized, double-blind trial. Domenica Lorusso, MD, PhD, director of Gynecological Oncology…
English